A) Inflammability B) Toxicity C) Corrosiveness D) Biocompatibility
A) To prevent regeneration B) To block cell growth C) To induce inflammation D) To provide a structure for cells to grow and organize
A) Chemical stability B) Fatigue resistance C) Biodegradability D) Thermal conductivity
A) High cost B) Biocompatibility C) Corrosion D) Heavy weight
A) Increase toxicity B) Enhanced surface interactions and properties C) Decrease biocompatibility D) Reduce mechanical strength
A) PMMA B) Silicone rubber C) Hydroxyapatite D) Polyethylene
A) Keratinocytes B) Fibroblasts C) Macrophages D) Red blood cells
A) To promote inflammation B) To increase toxicity C) To prevent infections D) To accelerate degradation
A) Quantum mechanics B) Marine biology C) Biomaterials science or biomaterials engineering D) Astrophysics
A) Biological materials are always synthetic B) Biomaterials cannot be used in medical applications C) Biomaterials are engineered, while biological materials are naturally produced D) There is no difference between them
A) Metallic components, polymers, ceramics, or composite materials B) Pure water-based solutions C) Only natural fibers D) Exclusively organic compounds
A) Through random trial and error methods B) Exclusively through animal testing C) Using only historical data without new testing D) By computational routines predicting molecular effects based on limited in vitro experimentation
A) The random distribution of particles in a solution. B) A process requiring mechanical manipulation to form structures. C) An assembly method that uses magnetic fields. D) The spontaneous aggregation of particles without external forces.
A) The chemical composition of particles. B) The external forces applied to the system. C) The temperature at which assembly occurs. D) The spatial scale of the unit cell (lattice parameter).
A) Random particle distribution. B) Self-organization. C) External guidance and control. D) Chemical bonding between particles.
A) 70 to 100 nm. B) 3 nm. C) 1.5 nm. D) 60 nm.
A) 80/20. B) About 60/40. C) 50/50. D) 70/30.
A) Randomly throughout the matrix. B) At the gaps between collagen fibrils. C) Within the mineral phase only. D) On the surface of tropocollagen molecules.
A) 1 μm diameter rods. B) 20 to 30 nm layers. C) "Bricks" with dimensions of 0.5. D) 60 nm diameter canals.
A) Collagen. B) Chitin. C) Hydroxyapatite. D) Calcium carbonate.
A) An amorphous structure. B) A helical pattern. C) A cubic pattern. D) A random distribution.
A) 60 nm. B) 70 to 100 nm. C) 1 μm. D) 20 to 30 nm.
A) ISO 14001 B) ISO 10993 C) ISO 9001 D) ISO 27001
A) Amino acids B) Fatty acids C) Nucleotides D) Sugars
A) Heart valve coating B) Bone graft substitute C) Artificial skin scaffold D) Dental filling material
A) Calcium sulfate B) Polyethylene terephthalate C) Pyrolytic carbon D) Stainless steel
A) Metal wires B) Plant fibers C) Animal skin D) Synthetic polymers
A) 10 different configurations B) 5 different configurations C) 20 different configurations D) 14 different configurations
A) Nylon B) Kevlar C) Dacron D) Spandex
A) Foreign body response (FBR) B) Inflammatory reaction C) Healing process D) Immune response
A) Ultra-structure level B) Molecular level C) Microstructure level D) Sub atomic level
A) 49% B) 60% C) 75% D) 25%
A) Electrically conductive B) Chemically reactive C) Non-biodegradable D) Mechanically strong
A) 20 to 30 nm. B) 1 μm. C) 60 nm. D) 3 nm.
A) 70 to 100 nm. B) Approximately 60 nm. C) 3 mm. D) 1.5 nm.
A) Biocompatibility B) Biofabrication C) Biodegradation D) Biomimetics
A) 2000s B) Later 1960s C) 1980s D) Early 1950s
A) Bone strengthening B) Drug delivery C) Wound closure D) Tissue growth stimulation
A) Chronic phase B) Healing phase C) Resolution phase D) Acute phase
A) Biocompatible B) Brittle C) Toxic D) Non-degradable
A) Size B) Shape C) Elasticity D) Alignment
A) Liposomes B) Polyetheretherketone (PEEK) C) Silica D) Polymers
A) Proteins B) DNA C) Starch D) Cellulose
A) Macrophages B) Neutrophils C) Lymphocytes D) Eosinophils
A) Graft-versus-host disease B) Foreign body response C) Biocompatibility D) Acute inflammation only
A) Joint replacements B) Dental implants C) Skin repair devices D) Contact lenses
A) No structures are isolated B) Only the damaged tissue C) Immune cells D) The implant
A) DNA B) Cellulose C) Silk D) Starch
A) Non-biodegradable B) Inert C) Toxic D) Biodegradable
A) Ductility B) Young's Modulus C) Tensile strength D) Flexural rigidity
A) Polypropylene (PP) B) Polyetherimide (PEI) C) Polycarbonate (PC) D) Cyclic olefin polymer (COP)
A) Avoid any interaction with the immune system B) Suppress the immune response entirely C) Direct the immune response rather than circumvent it D) Elicit a strong immune reaction
A) Compressive strength B) Elasticity C) Toughness D) Flexural rigidity
A) Ivory B) Aluminum C) Stainless steel D) Ceramic
A) X-ray Diffraction B) Nuclear Magnetic Resonance C) Scanning Electron Microscopy D) Mass Spectrometry
A) Point defects B) Line defects C) Edge dislocation D) Macrostructure |